NO154054C - Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater.

Info

Publication number: NO154054C
Authority: NO; Norway
Prior art keywords: preparation; therapeutic active; analogy procedure; hydroxypyrimidine derivatives; hydroxypyrimidine
Prior art date: 1979-03-10

Application number

NO800664A

Other languages

English (en)

Other versions

NO800664L (no

NO154054B (no

Inventor

Andre Esanu

Original Assignee

Soc D Etudes Prod Chimique

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-03-10

Filing date

1980-03-07

Publication date

1986-07-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO154054(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1980-03-07 Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique

1980-09-11 Publication of NO800664L publication Critical patent/NO800664L/no

1986-04-01 Publication of NO154054B publication Critical patent/NO154054B/no

1986-07-09 Publication of NO154054C publication Critical patent/NO154054C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO800664A 1979-03-10 1980-03-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater. NO154054C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB7908494		1979-03-10
GB7914987		1979-04-30

Publications (3)

Publication Number	Publication Date
NO800664L NO800664L (no)	1980-09-11
NO154054B NO154054B (no)	1986-04-01
NO154054C true NO154054C (no)	1986-07-09

Family

ID=26270867

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO800664A NO154054C (no)	1979-03-10	1980-03-07	Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater.

Country Status (24)

Country	Link
JP (1)	JPS55122768A (no)
AR (1)	AR222691A1 (no)
AU (1)	AU533547B2 (no)
BE (1)	BE881752A (no)
CA (1)	CA1132561A (no)
CH (1)	CH644368A5 (no)
DE (3)	DE3009071C2 (no)
EG (1)	EG14282A (no)
FI (1)	FI66357C (no)
FR (2)	FR2451191A1 (no)
GB (1)	GB2045756B (no)
HK (1)	HK55383A (no)
IE (1)	IE49547B1 (no)
IN (1)	IN153791B (no)
LU (1)	LU82185A1 (no)
MX (1)	MX6218E (no)
MY (1)	MY8400200A (no)
NL (1)	NL184833C (no)
NO (1)	NO154054C (no)
NZ (1)	NZ192927A (no)
OA (1)	OA06484A (no)
PT (1)	PT70882A (no)
SE (1)	SE435180B (no)
SG (1)	SG22683G (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE894517A (fr) *	1981-10-16	1983-01-17	Sod Conseils Rech Applic	Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4554276A (en) *	1983-10-03	1985-11-19	Pfizer Inc.	2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4673677A (en) *	1983-10-03	1987-06-16	Pfizer Inc.	Method for treatment of gastrointestinal disorders
US4711888A (en)	1985-07-24	1987-12-08	Pfizer Inc.	Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) *	1987-07-09	1989-01-26	Pfizer Inc.	2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) *	1988-06-28	1990-03-20	Pfizer Inc.	2-amino-5-hydroxy-4-pyrimidones
US5264435A (en) *	1988-12-29	1993-11-23	Mitsui Petrochemical Industries, Ltd.	Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
HU206337B (en) *	1988-12-29	1992-10-28	Mitsui Petrochemical Ind	Process for producing pyrimidine derivatives and pharmaceutical compositions
US4940712A (en) *	1989-05-26	1990-07-10	Pfizer Inc.	Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) *	1991-09-09	1993-12-14	Warner-Lambert Company	5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5196431A (en) *	1992-02-24	1993-03-23	Warner-Lambert Company	2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5220025A (en) *	1992-02-24	1993-06-15	Warner-Lambert Company	2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) *	2005-06-15	2015-09-15	Vanderbilt University	Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB741667A (en) *	1952-12-05	1955-12-07	Ici Ltd	New pyrimidine derivatives
GB756189A (en) *	1954-02-01	1956-08-29	Ici Ltd	New pyrimidine derivatives
ZA711152B (en) *	1970-03-02	1971-11-24	Ici Ltd	Manufacture of pyrimidines
GB1525995A (en) *	1976-02-18	1978-09-27	Soc D Etudes Prod Chimique	Aminopyrimidine salt

1980
- 1980-02-12 IN IN103/DEL/80A patent/IN153791B/en unknown
- 1980-02-15 BE BE0/199421A patent/BE881752A/fr not_active IP Right Cessation
- 1980-02-20 NZ NZ192927A patent/NZ192927A/xx unknown
- 1980-02-20 LU LU82185A patent/LU82185A1/fr unknown
- 1980-02-26 FI FI800566A patent/FI66357C/fi not_active IP Right Cessation
- 1980-02-27 AR AR280106A patent/AR222691A1/es active
- 1980-02-29 PT PT70882A patent/PT70882A/pt unknown
- 1980-03-03 CH CH165080A patent/CH644368A5/fr not_active IP Right Cessation
- 1980-03-04 CA CA346,981A patent/CA1132561A/en not_active Expired
- 1980-03-04 NL NLAANVRAGE8001289,A patent/NL184833C/xx not_active IP Right Cessation
- 1980-03-07 AU AU56248/80A patent/AU533547B2/en not_active Ceased
- 1980-03-07 GB GB8007908A patent/GB2045756B/en not_active Expired
- 1980-03-07 NO NO800664A patent/NO154054C/no unknown
- 1980-03-07 IE IE477/80A patent/IE49547B1/en unknown
- 1980-03-07 SE SE8001812A patent/SE435180B/sv not_active IP Right Cessation
- 1980-03-09 EG EG131/80A patent/EG14282A/xx active
- 1980-03-10 DE DE3009071A patent/DE3009071C2/de not_active Expired
- 1980-03-10 OA OA57049A patent/OA06484A/xx unknown
- 1980-03-10 MX MX808702U patent/MX6218E/es unknown
- 1980-03-10 FR FR8005277A patent/FR2451191A1/fr active Granted
- 1980-03-10 JP JP2931280A patent/JPS55122768A/ja active Granted
- 1980-03-10 FR FR8005278A patent/FR2451370A1/fr active Granted
- 1980-03-10 DE DE3050999A patent/DE3050999C2/de not_active Expired
- 1980-04-30 DE DE19803016752 patent/DE3016752A1/de active Granted
1983
- 1983-04-28 SG SG226/83A patent/SG22683G/en unknown
- 1983-11-17 HK HK553/83A patent/HK55383A/xx unknown
1984
- 1984-12-30 MY MY200/84A patent/MY8400200A/xx unknown

Also Published As

Publication number	Publication date
FR2451191B1 (no)	1983-04-29
AU533547B2 (en)	1983-12-01
IN153791B (no)	1984-08-18
OA06484A (fr)	1981-07-31
NL184833C (nl)	1989-11-16
FI66357B (fi)	1984-06-29
DE3009071A1 (de)	1980-09-11
FR2451370B1 (no)	1983-05-13
GB2045756B (en)	1983-01-26
DE3050999C2 (de)	1986-08-14
FI66357C (fi)	1984-10-10
NO800664L (no)	1980-09-11
DE3016752C2 (no)	1987-06-25
MY8400200A (en)	1984-12-31
EG14282A (en)	1983-09-30
DE3050999A1 (no)	1985-08-14
BE881752A (fr)	1980-05-30
FI800566A (fi)	1980-09-11
JPS6126996B2 (no)	1986-06-23
IE49547B1 (en)	1985-10-30
DE3009071C2 (de)	1985-11-14
FR2451370A1 (fr)	1980-10-10
NZ192927A (en)	1981-07-13
LU82185A1 (fr)	1980-06-06
NO154054B (no)	1986-04-01
JPS55122768A (en)	1980-09-20
PT70882A (en)	1980-03-01
DE3016752A1 (de)	1980-12-04
GB2045756A (en)	1980-11-05
SE8001812L (sv)	1980-09-11
SE435180B (sv)	1984-09-10
HK55383A (en)	1983-11-25
AU5624880A (en)	1980-09-18
SG22683G (en)	1983-12-16
NL184833B (nl)	1989-06-16
IE800477L (en)	1980-09-10
CA1132561A (en)	1982-09-28
NL8001289A (nl)	1980-09-12
CH644368A5 (en)	1984-07-31
NL184468B (nl)	1989-03-01
FR2451191A1 (fr)	1980-10-10
AR222691A1 (es)	1981-06-15
MX6218E (es)	1984-12-21

Similar Documents

Publication	Publication Date	Title
NO149102C (no)	1984-02-15	Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO158099C (no)	1988-07-13	Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO152899C (no)	1985-12-11	Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater.
NO157817C (no)	1988-05-25	Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater.
NO156864C (no)	1987-12-09	Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO161117C (no)	1989-07-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO156787C (no)	1987-11-25	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO152129C (no)	1985-08-07	Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO153569C (no)	1986-05-21	Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO153496C (no)	1986-05-14	Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
NO146396C (no)	1982-09-22	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO159654C (no)	1989-01-25	Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO154054C (no)	1986-07-09	Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater.
NO154013C (no)	1986-07-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive sesquiterpenderivater.
NO160079C (no)	1989-03-08	Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no)	1988-10-26	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no)	1989-04-26	Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO160512C (no)	1989-04-26	Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO151660C (no)	1985-05-15	Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.
NO168478C (no)	1992-02-26	Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO154052C (no)	1986-07-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.
NO152172C (no)	1985-08-14	Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO154088C (no)	1986-07-16	Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner.
NO801989L (no)	1981-01-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidopyrimidiner
NO152839C (no)	1985-11-27	Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.